Gonzalez, Jorge
Wageman, Joshua
Buchanan, Laura
Kalayjian, Tro
Calkins, Matthew
Saner, Erin
Soto-Mota, Adrian https://orcid.org/0000-0002-9173-7440
Article History
Received: 16 April 2026
Accepted: 11 August 2026
First Online: 24 August 2026
Declarations
Ethics approval and consent to participate: This study was conducted in accordance with the Declaration of Helsinki and was as IRB-exempt by the Wake Forest University Health Sciences- Wake Forest School of Medicine, Wake Forest University Institutional Review Board, with the reference code IRB00137763, and with a waiver of informed consent granted due to the retrospective nature of the study.
Consent for publication: All authors reviewed and approved the final manuscript.
Competing interests: Joshua Wageman is an employee of Amgen Inc. The other authors declare no competinginterests.